[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Rulemaking History for OTC Bronchodilator Drug Products
View by Date

Final Monograph (21 CFR part 341):
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use

OTC Bronchodilator Drug Products found on this page:

Note: This page links to PDF files which require the free Adobe Acrobat Reader.


Bronchodilator Drug Products: Original Active Ingredients and Labeling
Advance Notice Of Proposed Rulemaking Date FR Citation
Advance Notice of Proposed Rulemaking 9/9/1976 41FR38312
Notice: Prohibits single-ingredient theophylline marketing 12/10/1976

41FR54032

Reopening of Administrative Record 3/21/1980 45FR18400
Reopening of Administrative Record: Camphor-containing products 9/26/1980 45FR63874
Notice: Advisory Committee meeting 4/29/1983 48FR19470
Notice: Republication of 4/29/1983 notice 5/6/1983 48FR20502
Proposed Rule Date FR Citation
Tentative Final Monograph 10/26/1982 47FR47520
    Correction 1/25/1983 48FR3382
Final Rule Date FR Citation
Final Monograph 10/2/1986 51FR35326
    Correction 3/13/1987 52FR7830
    Correction 4/17/1987 52FR12521
Notice: OMB approval of final monograph 3/9/1987 52FR7126
Technical Amendment: Clarifies age range for children's dosage 9/15/1988 53FR45774

Bronchodilator Drug Products: Combination Products
Advance Notice Of Proposed Rulemaking Date FR Citation
Notice: Classifies caffeine, PPA, ephedrine combinations as nonmonograph 8/13/1982 47FR35344
Notice: Classifies caffeine, PPA, ephedrine, pseudoephedrine combinations as nonmonograph 11/18/1983 48FR52513
Proposed Rule Date FR Citation
Proposed Rule 8/12/1988 53FR30522
    Clarification: Promethazine HCl combinations 11/14/1988 53FR45774
Notice: Bans interim marketing of promethazine HCl combinations 9/5/1989 54FR36762
Reopening of Administrative Record: Promethazine HCl combinations 11/28/1989 54FR48914
    Correction 1/4/1990 55FR310
    Extension of Comment Period 1/24/1990 55FR2387
Proposed Rule: Classifies diphenhydramine HCl and citrate combinations as GRASE 2/23/1995 60FR10286
Proposed Rule: Classifies bronchodilator, expectorant, nasal decongestant combinations as nonmonograph 7/13/2005 70FR40232
Final Rule Date FR Citation
Final Rule: Nonmonograph combinations 9/27/2001 66FR49276
    Correction 10/19/2001 66FR53088
Final Rule: GRASE combinations 12/23/2002 67FR78158
    Technical Amendment: Correction 3/19/2007 72FR12730

Bronchodilator Drug Products: Ephedrine
Proposed Rule Date FR Citation
Proposed Rule: Classifies pressurized metered dose aerosol as nonmonograph 3/9/1995 60FR13014
Proposed Rule: Classifies ephedrine as nonmonograph 7/27/1995 60FR38643
    Correction 8/18/1995 60FR43091
Final Rule Date FR Citation
Final Rule: Classifies pressurized metered dose aerosol as nonmonograph 5/20/1996 61FR25142
    Correction 3/4/1997 62FR9684

Bronchodilator Drug Products: Monoamine Oxidase Inhibitor (MAOI
) Warning
Proposed Rule Date FR Citation
Proposed Rule: Requires warning 6/19/1992 57FR27662
    Extension of Comment Period 8/6/1992 57FR34733
Final Rule Date FR Citation
Final Rule 10/20/1993 58FR54238

Bronchodilator Drug Products: Revised Labeling After 1986 Final Monograph
Proposed Rule Date FR Citation
Proposed Rule: Revises indications, warnings, and directions 7/13/2005 70FR40237

top arrow Back to Top     back arrow Back to Rulemaking Index

Date updated: December 28, 2006; Last updated: October 26, 2007

horizonal rule